98 related articles for article (PubMed ID: 10806645)
1. Calanolide looks promising.
AIDS Patient Care STDS; 2000 Apr; 14(4):225-6. PubMed ID: 10806645
[No Abstract] [Full Text] [Related]
2. Calanolide A: a natural non-nucleoside reverse transcriptase inhibitor.
Hanna L
BETA; 1999 Apr; 12(2):8-9. PubMed ID: 11366704
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B.
Galinis DL; Fuller RW; McKee TC; Cardellina JH; Gulakowski RJ; McMahon JB; Boyd MR
J Med Chem; 1996 Oct; 39(22):4507-10. PubMed ID: 8893846
[TBL] [Abstract][Full Text] [Related]
4. Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers.
Eiznhamer DA; Creagh T; Ruckle JL; Tolbert DT; Giltner J; Dutta B; Flavin MT; Jenta T; Xu ZQ
HIV Clin Trials; 2002; 3(6):435-50. PubMed ID: 12501127
[TBL] [Abstract][Full Text] [Related]
5. Phase II begins for T-20.
AIDS Patient Care STDS; 1999 Sep; 13(9):567-8. PubMed ID: 10813040
[No Abstract] [Full Text] [Related]
6. Current strategies in the treatment of HIV infection.
Cohen OJ; Fauci AS
Adv Intern Med; 2001; 46():207-46. PubMed ID: 11147254
[No Abstract] [Full Text] [Related]
7. Quantification of (+)-calanolide A, a novel and naturally occurring anti-HIV agent, by high-performance liquid chromatography in plasma from rat, dog and human.
Xu ZQ; Norris KJ; Weinberg DS; Kardatzke J; Wertz P; Frank P; Flavin MT
J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):267-75. PubMed ID: 10901131
[TBL] [Abstract][Full Text] [Related]
8. Maturation inhibitors as new antiretroviral agents.
Richards J; McCallister S
J HIV Ther; 2008 Dec; 13(4):79-82. PubMed ID: 19418657
[No Abstract] [Full Text] [Related]
9. Chemical library and structure-activity relationships of 11-demethyl-12-oxo calanolide A analogues as anti-HIV-1 agents.
Ma T; Liu L; Xue H; Li L; Han C; Wang L; Chen Z; Liu G
J Med Chem; 2008 Mar; 51(5):1432-46. PubMed ID: 18284187
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial results of GEM91 show activity against advance HIV.
AIDS Patient Care STDS; 1997 Aug; 11(4):290-1. PubMed ID: 11361850
[No Abstract] [Full Text] [Related]
11. Antiretroviral doses.
AIDS Policy Law; 2001 Sep; 16(18):11. PubMed ID: 11591002
[No Abstract] [Full Text] [Related]
12. In vivo anti-HIV activity of (+)-calanolide A in the hollow fiber mouse model.
Xu ZQ; Hollingshead MG; Borgel S; Elder C; Khilevich A; Flavin MT
Bioorg Med Chem Lett; 1999 Jan; 9(2):133-8. PubMed ID: 10021914
[TBL] [Abstract][Full Text] [Related]
13. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
Xu ZQ; Barrow WW; Suling WJ; Westbrook L; Barrow E; Lin YM; Flavin MT
Bioorg Med Chem; 2004 Mar; 12(5):1199-207. PubMed ID: 14980631
[TBL] [Abstract][Full Text] [Related]
14. Review of recent guidelines for antiretroviral treatment of HIV-infected children.
Oleske JM
Top HIV Med; 2003; 11(6):180-4. PubMed ID: 14724326
[No Abstract] [Full Text] [Related]
15. SP-01A helps with quality of life.
AIDS Patient Care STDS; 2008 Feb; 22(2):160-1. PubMed ID: 18273942
[No Abstract] [Full Text] [Related]
16. [Therapy planning. It depends on the proper administration series].
MMW Fortschr Med; 2000 Mar; 142 Suppl 1():82-5. PubMed ID: 10863322
[No Abstract] [Full Text] [Related]
17. "Drug holidays" provide no benefits in HIV treatment.
Public Health Rep; 2004; 119(1):97. PubMed ID: 15174493
[No Abstract] [Full Text] [Related]
18. New CCR5 antagonist enters phase II trials. Drug would be first-line therapy.
AIDS Alert; 2008 Aug; 23(8):89-90. PubMed ID: 18724488
[No Abstract] [Full Text] [Related]
19. Concise synthesis of anti-HIV-1 active (+)-inophyllum B and (+)-calanolide A by application of (-)-quinine-catalyzed intramolecular oxo-Michael addition.
Sekino E; Kumamoto T; Tanaka T; Ikeda T; Ishikawa T
J Org Chem; 2004 Apr; 69(8):2760-7. PubMed ID: 15074925
[TBL] [Abstract][Full Text] [Related]
20. Tribulations and trials in HIV disease, Part I.
Boyle BA
AIDS Read; 2006 May; 16(5):240-4. PubMed ID: 16764065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
